Haleon PLC Sponsored ADR (NYSE:HLN) Given Average Rating of “Moderate Buy” by Analysts

Haleon PLC Sponsored ADR (NYSE:HLN) has been assigned a consensus recommendation of “Moderate Buy” from the nine analysts that are currently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, three have issued a hold recommendation, three have given a buy recommendation and two have assigned a strong buy recommendation to the company.

HLN has been the topic of a number of recent analyst reports. Wall Street Zen raised shares of Haleon from a “hold” rating to a “buy” rating in a research note on Sunday, July 12th. Weiss Ratings reissued a “hold (c)” rating on shares of Haleon in a research note on Tuesday, June 30th. Deutsche Bank Aktiengesellschaft restated a “sell” rating on shares of Haleon in a report on Thursday, April 30th. Finally, Rothschild & Co Redburn lowered Haleon from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, June 16th.

Haleon Price Performance

Haleon stock opened at $10.10 on Wednesday. Haleon has a 1 year low of $8.65 and a 1 year high of $11.28. The firm has a 50 day moving average price of $9.27 and a 200 day moving average price of $9.86. The company has a market cap of $44.46 billion, a price-to-earnings ratio of 25.88, a PEG ratio of 2.34 and a beta of 0.13. The company has a debt-to-equity ratio of 0.47, a quick ratio of 0.71 and a current ratio of 0.92.

Institutional Investors Weigh In On Haleon

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Norges Bank acquired a new position in shares of Haleon during the 4th quarter valued at $163,529,000. Natixis Advisors LLC boosted its position in Haleon by 429.8% during the 4th quarter. Natixis Advisors LLC now owns 10,003,941 shares of the company’s stock worth $101,140,000 after purchasing an additional 8,115,633 shares during the period. Arrowstreet Capital Limited Partnership increased its holdings in Haleon by 4,315.4% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 8,027,189 shares of the company’s stock valued at $81,155,000 after purchasing an additional 7,845,391 shares in the last quarter. Bank of Montreal Can increased its holdings in Haleon by 454.1% in the 4th quarter. Bank of Montreal Can now owns 8,500,496 shares of the company’s stock valued at $85,940,000 after purchasing an additional 6,966,416 shares in the last quarter. Finally, Bank of America Corp DE raised its position in Haleon by 116.7% in the second quarter. Bank of America Corp DE now owns 12,384,135 shares of the company’s stock valued at $128,423,000 after purchasing an additional 6,669,923 shares during the period. 6.67% of the stock is currently owned by institutional investors and hedge funds.

About Haleon

Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over‑the‑counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self‑care and symptom relief.

The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.